Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionCaptrust Financial Advisors
Latest Disclosed Ownership161,008 shares
Latest Disclosed Value $ 24,593,932
Captrust Financial Advisors reports 0.15% decrease in ownership of NVS / Novartis AG - Depositary Receipt (Common Stock)

On May 14, 2026 - Captrust Financial Advisors filed a 13F-HR form disclosing ownership of 161,008 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $24,593,972 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 161,252 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of -0.15% during the quarter. The current value of the position is $23,893,587 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 161,008 -244 -0.15 24,594 10.62 0.0424
2026-02-17 2025-12-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 161,252 7,103 4.61 22,232 12.46 0.0423
2025-11-19 2025-09-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 154,149 2,884 1.91 19,768 8.00 0.0403
2025-08-15 2025-06-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 151,265 11,674 8.36 18,305 17.63 0.0408
2025-05-15 2025-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 139,591 17,927 14.73 15,562 31.44 0.0390
2025-02-14 2024-12-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 121,664 -9,381 -7.16 11,839 -21.45 0.0338
2024-11-14 2024-09-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 131,045 1,730 1.34 15,073 9.49 0.0447
2024-08-15 2024-06-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 129,315 2,534 2.00 13,767 12.26 0.0443
2024-05-15 2024-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 126,781 -14,338 -10.16 12,264 -13.93 0.0451
2024-02-14 2023-12-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 141,119 747 0.53 14,249 -0.35 0.0491
2023-11-15 2023-09-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 140,372 10,829 8.36 14,298 9.38 0.0546
2023-08-15 2023-06-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 129,543 15,196 13.29 13,072 24.27 0.0515
2023-05-15 2023-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 114,347 4,285 3.89 10,520 5.36 0.0462
2023-02-15 2022-12-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 110,062 -744 -0.67 9,985 18.55 0.0502
2022-11-16 2022-09-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 110,806 14,877 15.51 8,422 3.86 0.0490
2022-08-23 2022-06-30 13F/A-1 NOVARTIS AG SPONSORED ADR ADR 66987V109 95,929 9,410 10.88 8,109 6.81 0.0523
2022-08-16 2022-06-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 103,535 103,527 8,752 0.0635
2022-05-16 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 86,519 1,645 1.94 7,592 2.26 0.0491
2022-02-14 2021-12-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 84,874 1,975 2.38 7,424 9.51 0.0509
2021-11-16 2021-09-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 82,899 4,505 5.75 6,779 -5.23 0.0563
2021-08-16 2021-06-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 78,394 -2,691 -3.32 7,153 3.20 0.0666
2021-05-17 2021-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 81,085 3,362 4.33 6,931 -5.56 0.0750
2021-02-16 2020-12-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 77,723 2,259 2.99 7,339 11.40 0.0972
2020-11-17 2020-09-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 75,464 -948 -1.24 6,588 -1.86 0.1093
2020-08-14 2020-06-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 76,412 3,455 4.74 6,713 13.70 0.1106
2020-05-15 2020-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 72,957 410 0.57 5,904 -14.29 0.1301
2020-02-14 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 72,547 72,547 6,888 0.1087
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.